Wegovy has gained attention as a powerful weight loss medication, especially for those struggling with obesity. However, if ...

Medicare must recognize obesity as a chronic disease and provide coverage for the treatments that can help those who struggle ...

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.

Minnesota lawmakers are once again calling on insurance companies to cover anti-obesity medications like Ozempic and Wegovy ...

Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

It’s time to treat obesity as a chronic disease and have Medicare cover these life-changing AOMs. By taking action now, we ...

Obesity Care Week (OCW) returns for its annual global campaign aimed at raising awareness, educating and advocating for individuals affected by obesity. This year's theme, "Commit to Care," emphasizes ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

Medicare, the government-backed program for ... Ozempic, which has also been used off-label for obesity, saw a more than 16-fold rise in spending to $9.2 billion in 2023 from 2019 - roughly ...